Application Outlook Based on Application, the market is segmented into Chronic Pain, Urinary & Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, and ...
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American ...
Dublin, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. Neuromodulation is gaining ...
This report aims to provide detailed insights into the Neuromodulation Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the ...
The global neuromodulation devices market is poised to witness substantial growth, projected to expand at a CAGR of 9–11% over the next five years. This growth is primarily driven by the increasing ...
New York, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology ; ...
Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued ...
Research and Markets has announced the addition of the "Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 - Global Analysis" report to their offering. Market ...
SYDNEY, Australia - The International Neuromodulation Society (INS) will hold its 14th World Congress from May 25 through May 30, 2019 in Sydney, Australia. The multidisciplinary meeting highlights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results